(Q37235638)

19 August 2017

1 reference

title

Pharmacogenetics in colorectal cancer: a systematic review (English)

1 reference

19 August 2017

1 reference

1 reference

1 reference

3

Jenny Chang-Claude

0 references

Hermann Brenner

series ordinal

2

object named as

Hermann Brenner

1 reference

19 August 2017

1

Silvia Funke

1 reference

19 August 2017

publication date

1 August 2008

1 reference

19 August 2017

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

8

1 reference

19 August 2017

page(s)

1079-1099

1 reference

Global cancer statistics, 2002

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Advances in pharmacogenetics and pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Pharmacogenomics--drug disposition, drug targets, and side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Measuring the value of pharmacogenomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Thymidylate synthase and methylenetetrahydrofolate reductase gene polymorphism in normal tissue as predictors of fluorouracil sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Thymidylate synthase gene polymorphism predicts toxicity in colorectal cancer patients receiving 5-fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Cyclopenta(f)isoquinoline derivatives designed to bind specifically to native deoxyribonucleic acid. 3. Interaction of 6-carbamylmethyl-8-methyl-7H-cyclopenta(f)isoquinolin-3(2H)-one with deoxyribonucleic acids and polydeoxyribonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Dihydropyrimidine dehydrogenase and thymidylate synthase polymorphisms and their association with 5-fluorouracil/leucovorin chemotherapy in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Prospective randomized comparison of fluorouracil versus fluorouracil and high-dose continuous infusion leucovorin calcium for the treatment of advanced measurable colorectal cancer in patients previously unexposed to chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Thymidylate synthase gene polymorphism predicts response to capecitabine in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Adjuvant therapy with raltitrexed in patients with colorectal cancer intolerant of 5-fluorouracil: British Columbia Cancer Agency experience

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Thymidylate synthase expression in colorectal cancer: a prognostic and predictive marker of benefit from adjuvant fluorouracil-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Thymidylate synthase gene polymorphism determines response and toxicity of 5-FU chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Uridine diphosphate glucuronosyl transferase 1A1 promoter polymorphism predicts the risk of gastrointestinal toxicity and fatigue induced by irinotecan-based chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Orotate phosphoribosyltransferase gene polymorphism predicts toxicity in patients treated with bolus 5-fluorouracil regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Methylenetetrahydrofolate reductase gene polymorphisms and response to fluorouracil-based treatment in advanced colorectal cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Methylenetetrahydrofolate reductase gene polymorphisms: genomic predictors of clinical response to fluoropyrimidine-based chemotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

MTHFR (C677T) polymorphisms and stage III colon cancer: response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Association of methylenetetrahydrofolate reductase gene polymorphisms and sex-specific survival in patients with metastatic colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Prognostic value of tumoral thymidylate synthase and p53 in metastatic colorectal cancer patients receiving fluorouracil-based chemotherapy: phenotypic and genotypic analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Oxaliplatin: pharmacokinetics and chronopharmacological aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Cellular and molecular aspects of drugs of the future: oxaliplatin.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Acute oxaliplatin-induced peripheral nerve hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

A review of oxaliplatin and its clinical use in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Pharmacogenetics of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Association between glutathione S-transferase P1, T1, and M1 genetic polymorphism and survival of patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Allelic variants of the human glutathione S-transferase P1 gene confer differential cytoprotection against anticancer agents in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

An evolutionary perspective on single-nucleotide polymorphism screening in molecular cancer epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Relevance of different UGT1A1 polymorphisms in irinotecan-induced toxicity: a molecular and clinical study of 75 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Biliary transport of irinotecan and metabolites in normal and P-glycoprotein-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Targeting the epidermal growth factor receptor in metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Multicenter phase II and translational study of cetuximab in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin, and fluoropyrimidines

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Genome-wide association studies for complex traits: consensus, uncertainty and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Tumor Thymidylate Synthase 1494del6 Genotype As a Prognostic Factor in Colorectal Cancer Patients Receiving Fluorouracil-Based Adjuvant Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

Glutathione S-Transferase P1 Polymorphism (Ile105Val) Predicts Cumulative Neuropathy in Patients Receiving Oxaliplatin-Based Chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

UGT1A1 Polymorphism Can Predict Hematologic Toxicity in Patients Treated with Irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.9.8.1079

10.2217/14622416.9.8.1079

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference